Authors


Angela Zhu, MD

Latest:

Envision Summit 2025: Pearls for pediatric cataract surgery

At the Envision Summit 2025 in San Juan, Puerto Rico, Angela Zhu, MD, offered advice on cataract surgery for all ages, focusing on pediatrics.


Alain M. Bron, MD

Latest:

MIGS helping to personalize glaucoma surgery options

Although minimally invasive procedure gives hope, additional research is required.


Lee MacMorris

Latest:

Evolution of optical coherence tomography of the human eye

Adolf Fercher's 2D image of fundus paved way for today’s imaging technique.


SriniVas R. Sadda, MD, FARVO

Latest:

SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD

Improved axial resolution allows clearer visualization of early atrophic changes, including iRORA vs cRORA differentiation, as shared at the Heidelberg 2025 International SPECTRALIS Symposium – And Beyond (ISS).


Giselle Ricur, MD

Latest:

The future of ophthalmology training is here—and it’s digital

Virtual reality and artificial intelligence are reshaping medical education.


Thomas Aaberg Jr, MD

Latest:

A roadmap to preserving the prime years of patients diagnosed with MacTel

According to Thomas Aaberg, MR, the novel therapy is geared to treat rare, debilitating eye disease.


Sapna Gangaputra, MD, MPH

Latest:

Diagnostic Maze: Navigating the complexity of isolated optic disc edema in syphilitic uveitis

With cases of syphilitic uveitis on the rise, recognizing its varied presentations—including optic disc edema, which may appear without other significant eye inflammation—is increasingly important for timely diagnosis and treatment.


Winston Posvar, OD, MS

Latest:

The future of decentralized clinical trials in ophthalmology

Research can drive opportunities for patients with rare diseases


Randy McNamara

Latest:

Fulfilling expectations: A super highway to workability

A powerful conversation about expectations can open communication and trust.


Christine Larsen, MD

Latest:

Adherence and tolerability are key in treatment of hypertension and glaucoma

Priorities can ensure optimal outcomes for patients diagnosed with diseases.


Daniel F Kiernan, MD, FACS

Latest:

Impressions and Takeaways From Patient Case #2

Daniel F Kiernan, MD, FACS, discusses the use of anti-inflammatory treatment when experiencing sub-optimal response with anti-VEGF therapy in DME.


Sonya Besagar, MD

Latest:

Diagnostic Maze: Navigating the complexity of isolated optic disc edema in syphilitic uveitis

With cases of syphilitic uveitis on the rise, recognizing its varied presentations—including optic disc edema, which may appear without other significant eye inflammation—is increasingly important for timely diagnosis and treatment.


Sharon Fekrat, MD, FACS, FASRS

Latest:

Q&A: Sharon Fekrat, MD, FACS, FASRS, on the value of scientific meetings and collaboration

Sharon Fekrat, MD, FACS, FASRS, highlights the critical importance of networking and collaboration in the medical field, particularly in ophthalmology.


Jason Smith, DNP, CRNA

Latest:

Study finds sublingual troche, IV sedation are equivalent for cataract surgery

The method by which sedation is applied to keep patients relaxed and comfortable throughout cataract surgery can be tailored similar to that of anesthesia — surgical anesthesia is not a one size fits all endeavor.


Brian Woods, MBBCh

Latest:

Artificial intelligence enhances detection of neuro-ophthalmic disorders

Deep learning discerns IIH, NAION, and normal eyes using single fundus image.


Ashley A. Ooms, MD

Latest:

DMEI resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO poster

Ooms' poster at the Association of University Professors of Ophthalmology annual meeting highlighted a study on gray area complications in strabismus surgery, showing that trainees are more likely than attendings to disclose these complications despite having similar baseline anxiety levels. Ooms is a PGY-4 ophthalmology resident at the Dean McGee Eye Institute.


Victor A. Augustin, MD

Latest:

Artificial DMEK could help tackle endothelial donor tissue shortage

New acrylic implant provides option for patients with endothelial dysfunction.


Marc R. Bloomenstein, OD, FAAO

Latest:

Topical presbyopic correction: a postoperative problem solver

Presbyopia-correcting drops represent a whole new product category—one with a lot of upsides for clinicians who want to help their patients see well at all distances.


Vasant Raman, MS, FRCS

Latest:

Should nonclinicians inject dexamethasone implants?

Studies on nurse-led services find a low level of complications among patients.


Michael Greenwood, MD

Latest:

Advantages of incorporating ECP into the surgeon’s armamentarium

Short learning curve, significant clinical advantages make this a comfortable addition.


Saif Alryalat, MD

Latest:

What ophthalmologists need to know about neuromyelitis optica spectrum disorder

Early diagnosis of NMOSD is key to preventing disability, improving survival.


Phillip H. Phan, PhD

Latest:

Clearing hurdles to large scale telemedicine adoption

During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye


Steven Ferrucci, OD, FAAO

Latest:

ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTS

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.


Bryce W. Polascik, BS

Latest:

Welcome to the metaverse: Technology allows ophthalmologists to mingle with colleagues worldwide

Answers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.


Anisha Kasi

Latest:

ARVO 2025: Inflammatory eye disorders in hidradenitis suppurativa patients

At ARVO 2025, in Salt Lake City, Utah, Anisha Kasi talked about her presentation on how her team used the TriNetX database, a large database of over 150 million patients worldwide, to validate the connection between hidradenitis suppurativa and inflammatory eye conditions.


Esteban Peralta Chacon, MD

Latest:

Post-LASIK presbyopia: Meeting expectations with evolving technology

Innovation, adaptability, and clear communication are key to managing outcomes.


Ellen Koo, MD

Latest:

ARVO 2025: First in-human clinical trials results from magnetic cell therapy

Ellen Koo, MD, presented data from first in-human clinical trials, looking at the results from magnetic cell therapy and reports on the efficacy and safety in the patients.


Edward Yung, MD

Latest:

Long-Term Outcomes After Nonimplant MIGS Procedure

A panelist discusses how nonimplant MIGS, such as viscocanaloplasty and viscoelastic delivery devices, offer long-term IOP reduction and medication savings, emphasizing their benefits for early intervention and improved postoperative quality of life, while noting limitations for more advanced glaucoma conditions.


Adrienne Graves, PhD

Latest:

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

The 14th annual Glaucoma 360 conference, co-founded by Adrienne Graves, PhD, and Andrew Iwach, MD, and hosted by Glaucoma Research Foundation, will be held from February 6-8, 2025, at the Westin St. Francis in San Francisco, California. The event will focus on the latest advancements in glaucoma care and encourage innovation and collaboration.


Robert Fintelmann, MD, FACS

Latest:

Monitor keratoconus progression after cross-linking treatment

Contemporary scleral lenses work so well that stable vision in them cannot necessarily be taken as a sign that KC progression has stopped. Determination of KC progression requires advanced imaging.

© 2025 MJH Life Sciences

All rights reserved.